These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22197106)

  • 21. Repetitive Implantable Cardioverter Defibrillator Shocks: What is the Mechanism?
    Iwasawa J; Miyazaki S; Hachiya H; Iesaka Y
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):899-901. PubMed ID: 26132722
    [No Abstract]   [Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator shock during physical activity: appropriate or inappropriate shock?
    Chemello D; Chin A; Morillo C; Divakaramenon S
    Pacing Clin Electrophysiol; 2013 May; 36(5):635-8. PubMed ID: 23127226
    [No Abstract]   [Full Text] [Related]  

  • 23. Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm.
    Mansour F; Guash E; Berruezo A; Brugada J; Tolosana JM; Mont L
    Europace; 2009 Aug; 11(8):1120-2. PubMed ID: 19443435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-wave oversensing and inappropriate shocks: a case report.
    Srivathsan K; Scott LR; Altemose GT
    Europace; 2008 May; 10(5):552-5. PubMed ID: 18442965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
    Duggirala HJ; Herz ND; Caños DA; Sullivan RA; Schaaf R; Pinnow E; Marinac-Dabic D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):87-93. PubMed ID: 22095760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limitation of programmed alerts to predict ICD lead failures.
    Vlay SC
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):554-5. PubMed ID: 19335870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Redetection of tachycardia in severe ventricular undersensing].
    Steffel J
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):240-3. PubMed ID: 27459975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shock whilst gardening--implantable defibrillators & lawn mowers.
    Von Olshausen G; Lennerz C; Grebmer C; Pavaci H; Kolb C
    QJM; 2014 Feb; 107(2):147-9. PubMed ID: 24023069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers.
    Kanoupakis EM; Manios EG; Vardas PE
    Europace; 2009 Nov; 11(11):1434-9. PubMed ID: 19801563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lead thrombi associated with externalized cables on Riata ICD leads: a case series.
    Goyal SK; Ellis CR; Rottman JN; Whalen SP
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1047-50. PubMed ID: 23577693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troubleshooting of small R-wave with inappropriate implantable cardioverter-defibrillator shock.
    Baldinger SH; Kadner A; Delacrétaz E
    Europace; 2014 Jun; 16(6):854. PubMed ID: 24008497
    [No Abstract]   [Full Text] [Related]  

  • 35. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead.
    Maytin M; Love CJ; Fischer A; Carrillo RG; Garisto JD; Bongiorni MG; Segreti L; John RM; Michaud GF; Albert CM; Epstein LM
    J Am Coll Cardiol; 2010 Aug; 56(8):646-50. PubMed ID: 20598467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of lead safety recommendations.
    VAN Rees JB; Borleffs CJ; Bax JJ; Nagtegaal EM; VAN DER Velde ET; VAN Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):431-6. PubMed ID: 19954503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.
    Hauser RG; Maisel WH; Friedman PA; Kallinen LM; Mugglin AS; Kumar K; Hodge DO; Morrison TB; Hayes DL
    Circulation; 2011 Feb; 123(4):358-63. PubMed ID: 21242478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lightning induced inappropriate ICD shock: an unusual case of electromagnetic interference.
    Anderson DR; Gillberg JM; Torrey JW; Koneru JN
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e159-62. PubMed ID: 20883513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inappropriate shocks after implantable cardioverter-defibrillator for primary prevention in idiopathic cardiomyopathy: Independent determinants.
    Safak E; D'Ancona G; Ince H
    Int J Cardiol; 2016 Nov; 223():512-513. PubMed ID: 27552567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.